At a Glance
- Tasks: Conduct innovative research on therapeutic nucleosides and bioprocess strategies.
- Company: The University of Manchester, a leading institution in chemistry research.
- Benefits: Fully funded PhD with a tax-free stipend and covered tuition fees.
- Other info: Collaborative environment with opportunities for personal and professional growth.
- Why this job: Join a vibrant research community and contribute to groundbreaking drug discovery.
- Qualifications: First-class honours degree in chemistry or related field required.
The predicted salary is between 20780 - 20780 £ per year.
The University of Manchester’s School of Chemistry invites applications for a fully funded PhD studentship in Bioprocess: Skeletal Editing of Therapeutic Nucleosides. This research opportunity offers a 3.5-year doctoral programme starting in 2026, situated within a vibrant and collaborative research environment.
The project will explore innovative bioprocess strategies and skeletal editing methodologies to create and optimise novel therapeutic nucleoside structures, advancing the frontiers of synthetic and medicinal chemistry. Research will span the development and application of cutting-edge organic synthesis, analytical techniques, and biocatalytic processes. The successful candidate will work closely with leading faculty, contributing to impactful research with potential implications for drug discovery and bioprocess development.
Eligibility Criteria
Applicants should hold, or be on track to obtain, a first-class honours degree (or equivalent) in chemistry or a closely related discipline. Applicants must demonstrate a strong academic record and a keen interest in research. While the studentship is primarily available to home students, all eligible applicants should check individual funding criteria.
Required expertise/skills
Ideal candidates will have substantial laboratory experience in organic chemistry, including familiarity with chemical synthesis, reaction optimisation, and analytical characterisation techniques. Ability to think independently, work collaboratively in a research team, and engage with complex scientific problems is essential.
Salary details
The studentship includes a tax-free annual stipend set at the UKRI minimum rate (approximately £20,780 for 2025/26), with tuition fees fully covered at the home rate. Stipend increases are expected each year.
Application Deadline
The closing date for applications is 31 March 2026.
PhD Studentship – Bioprocess: Skeletal Editing of Therapeutic Nucleosides in Manchester employer: RFCSR
At King’s College London, we pride ourselves on being an exceptional employer that fosters a collaborative and innovative work culture. Our interdisciplinary approach not only encourages professional growth through diverse research opportunities but also allows you to make a meaningful impact in the fields of engineering and biomedical research. Located in the vibrant city of London, our institution offers a dynamic environment where creativity thrives and employees are supported in their career development.
